A new strategy of drug treatment in NSAID--unresponsive ankylosing spondylitis.
Chogle
A R
AR
Mishra
Hemali
H
Chakravarty
Anamika
A
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D004164:Diphosphonates / Q000627:therapeutic use*; D006801:Humans; D008727:Methotrexate / Q000627:therapeutic use*; D008775:Methylprednisolone / Q000627:therapeutic use*; D000077268:Pamidronate; D013167:Spondylitis, Ankylosing / Q000188:drug therapy*; D012460:Sulfasalazine / Q000627:therapeutic use*; D017211:Treatment Failure; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
D000893:Anti-Inflammatory Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D000964:Antimetabolites, Antineoplastic; D018501:Antirheumatic Agents; D004164:Diphosphonates; D014409:Tumor Necrosis Factor-alpha; D012460:Sulfasalazine; D000077268:Pamidronate; D008775:Methylprednisolone; D008727:Methotrexate